H3K9 methylation drives resistance to androgen receptor–antagonist therapy in prostate cancer
Ontology highlight
ABSTRACT: H3K9 methylation drives resistance to androgen receptor–antagonist therapy in prostate cancer
PROVIDER: PRJNA835482 | ENA |
REPOSITORIES: ENA
ACCESS DATA